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 ORIGINAL ARTICLE 
 Presenting the improved possibility for staying well might be better 
than talking about change in risk: Use of the Non-Occurrence 
Probability Increase (NOPI) 
 BERTIL  HAGSTR Ö M ,  RONNY K.  GUNNARSSON  &  MARK  ROSENFELD 
 Research and Development Unit, Primary Health Care and Dental Care, Southern  Ä lvsborg County, 
Region V ä stra G ö taland, Sweden 
 Abstract 
 Objective. Talking about risk with patients is problematic since the individual ’ s risk is not addressed and is usually very low. 
This study aimed to see how fact presentation infl uenced the decision-making process for general practitioners concerning 
treatment for the prevention of cardiovascular disease. Rather than looking at the risk of becoming ill, often presented as 
high fi gures of relative risk reduction (RRR), it could be useful to present the probability of staying well, i.e. from the 
concept of non-occurrence probability (NOP) and non-occurrence probability increase (NOPI)  – simply a single measure 
of change in NOP.  Design. General practitioners (GPs) had personal response keypads to answer two questions, presented 
differently, concerning whether they would allow themselves to be treated or not be treated for the risk of cardiovascular 
death.  Setting and subjects. Five audiences consisting of general practitioners attending lectures.  Results. When the question 
was presented as RRR, 68% and 86%, respectively, of the physicians responded that they would take the decision to treat. 
When presented as the concept of NOPI the fi gures were reduced to 18% and 16%, respectively (p    10 – 6).  Implications. 
Developing tools to explain treatment effect is crucial to enhancing health care quality. Since NOPI is one potential way 
of presenting prevention of risk we encourage future research to evaluate the NOPI concept compared with RRR and 
absolute risk reduction (ARR). 
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persuasive [3,4]. However, it is uncertain whether 
presenting RRR is likely to help patients make deci-
sions about medication more consistent with their 
own values. ARR is supposedly more interesting than 
RRR. Whether a drug reduces mortality from 2% to 
1% or from 40% to 20% is essential. 
 Another perspective is NOP, which makes the 
magnitude of  “ the risk ” more understandable [5,6]. 
The lack of research is considerable [3]. This report 
aimed to investigate how another perspective on 
treatment effect and presentation infl uences the phy-
sician ’ s attitude. 
 Material and methods 
 BH gave fi ve lectures to primary care physicians 
(GPs) on medication for risk reduction in Sweden 
 Introduction 
 Talking about risk with patients is problematic since 
the individual ’ s risk is not addressed. Furthermore, 
words infl uence thought and behaviour and the use 
of the word  “ risk ” may cause worry [1,2]. Under-
standable ways of discussing risk are essential. This 
short communication introduces two acronyms, 
NOP (non-occurrence probability) and NOPI (non-
occurrence probability increase), whereby it is pos-
sible to avoid the concept of risk. 
 If a treatment gives a relative risk reduction 
(RRR) for a major cardiovascular event by 50% in a 
population the benefi t (to society) seems obvious 
even though absolute risk reduction (ARR) is low. 
Presenting a question differently, such as both by 
RRR and as ARR, has a considerable effect on the 
intended use of a treatment and RRR seems more 
 Correspondence: Bertil Hagstr ö m, Research and Development Unit, Primary Health Care and Dental Care, Southern  Ä lvsborg County, Region V ä stra 
G ö taland, Sven Erikssonplatsen 4, S-503 38 Bor å s, Sweden. Tel:   46-70 564 393 7. E-mail: bertil.hagstrom@telia.com 



























































  Staying well versus change in risk and use of the NOPI  139
from September 2007 to March 2009 to audiences 
of 145 persons who were representative of Swedish 
GPs. Before discussing the risk concept two exam-
ples of treatment effects were presented: fi rst as 
RRR and shortly after as the non-occurrence prob-
ability increase NOPI  – a single measure of NOP 
change. 
 The two examples were fi rst presented as RRR 
without baseline probability:  “ Would you reduce 
your risk for cardiovascular death by 50% during a 
10-year period with medication? ” [7], and  “ Would 
you reduce your risk by 33% for a cardiovascular 
event during a 3 – 4 year period with medication? ” [8]. 
Then as NOPI:  “ Would you increase your chance of 
avoiding a cardiovascular death during a 10-year 
period from 98% to 99% with medication? ” [7], and 
 “ Would you increase your chance of avoiding a car-
diovascular event during a 3 – 4 year period from 97% 
to 98% with medication? ” [8]. The audience responses 
to the questions were recorded using an audience 
response system of personal response keypads and 
a response receiver (Turning point  ®  by Turning 
Technologies). 
 Results 
 When the fi rst example was presented as RRR 68% 
of the primary care physicians agreed (90/132), and 
when presented as NOPI only 18% agreed (25/136). 
When the second example was presented as RRR 
86% agreed (55/64), and when presented as NOPI 
16% agreed (10/62) (Table I). The difference between 
RRR and NOPI was of similar magnitude regardless 
of whether the example described an uncomplicated 
(example 1) or a high-risk patient (example 2). 
 Discussion 
 In this study we compared the agreement to treatment 
options for cardiovascular preventive medication pre-
sented either as RRR or as NOPI to a group of 
Swedish GPs. We found that few physicians accepted 
pharmacological treatment when the effect was pre-
sented as NOPI while most would accept treatment 
when the effect was presented as RRR. Physicians per-
ceived the options completely inversely depending on 
how treatment effect was presented [9]. 
 There are methodological weaknesses in an 
audience-response system. However, it was estimated 
that more than 90% responded to each question. The 
second question was added to the lectures later than 
 Developing tools to explain treatment effect  •
is crucial to enhancing health care quality. 
 The Non-Occurrence Probability Increase  •
(NOPI) provides patients with a more real-
istic view of how treatment alters the prob-
ability of staying well than the RRR, which 
presents the lowered risk of becoming ill. 
RRR and NOPI may be considered highly 
divergent in the presentation of treatment 
effects and strongly affect physician decision-
making concerning medication. 
 Table I. General practitioners ’ perception of the difference between risk and chance. 
Treatment effect presented as 
relative risk reduction (RRR)
Treatment effect presented as non-
occurrence probability increase (NOPI)
P-value 
(chi-squared 
with Yates ’ s 
correction)
Example 1: You are a 
55-year-old woman. 
Drugs may affect 
probability of future 
cardiovascular death a 
Would you reduce your risk for a 
cardiovascular death during a 
10-year period by 50% with 
medication?
68% (90/132) of GPs said yes
Would you increase your chance of 
avoiding a cardiovascular death during a 
10-year period from 98% to 99% with 
medication?
18% (25/136) of GPs said yes
   0.001
Example 2: You are a 
60-year-old man and 
have at least two risk 
factors  – smoking, stroke, 
transient ischaemic 
attack (TIA), or 
hereditary  – for 
cardiovascular disease 
Drugs may affect the 
probability of a future 
cardiovascular event? b 
Would you reduce your risk for a 
cardiovascular event during a 
3 – 4 year period by 33% with 
medication?
86% (55/64) of GPs said yes
Would you increase your chance of 
avoiding a cardiovascular event during a 
3 – 4 year period from 97% to 98% with 
medication?
16% (10/62) of GPs said yes
   0.001
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the fi rst and therefore had fewer respondents, and 
was also presented after the fi rst and could therefore 
have introduced a systematic error. A better approach 
might have been to let GPs answer only the examples 
presented with either RRR or NOPI, not both. How-
ever, it seems unlikely that this potential error would 
explain all the difference between RRR and NOPI 
option responses. One can argue that conceptual 
confusion may arise when comparing RRR with 
NOPI. Both RRR and ARR deal with the lowered 
risk of becoming ill while NOPI deals with the 
increased chance of staying well. Thus, RRR and 
NOPI are extreme opposites in how treatment effect 
is presented. 
 Risk evaluation is complex and the word risk 
might be frightening to some patients [10,11]. Talk-
ing about increased probability of staying healthy 
may therefore be a better option. Yet, a NOP increase 
from 98% to 99% giving a NOPI of 1% is not as 
convincing an argument as a 50% relative risk reduc-
tion for cardiovascular death [12]. Not even the GPs 
in this study chose treatment when NOPI was 
small. 
 Developing tools to explain treatment effect is 
crucial to enhancing health care quality [13 – 16]. 
Since NOPI is one potential way of presenting 
prevention of risk we encourage future research to 
evaluate the NOPI concept compared with RRR 
and ARR. 
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